Overview

Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
A study to assess the safety and efficacy of the IV drug infliximab for the treatment of hidradenitis suppurativa
Phase:
Phase 2
Details
Lead Sponsor:
Florida Academic Dermatology Centers
Treatments:
Infliximab